These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21427085)

  • 1. Inhibition of mutant huntingtin expression by RNA duplex targeting expanded CAG repeats.
    Fiszer A; Mykowska A; Krzyzosiak WJ
    Nucleic Acids Res; 2011 Jul; 39(13):5578-85. PubMed ID: 21427085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-duplexing CUG repeats selectively inhibit mutant huntingtin expression.
    Fiszer A; Olejniczak M; Galka-Marciniak P; Mykowska A; Krzyzosiak WJ
    Nucleic Acids Res; 2013 Dec; 41(22):10426-37. PubMed ID: 24038471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference.
    de Mezer M; Wojciechowska M; Napierala M; Sobczak K; Krzyzosiak WJ
    Nucleic Acids Res; 2011 May; 39(9):3852-63. PubMed ID: 21247881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of allele-selective inhibition of huntingtin expression by duplex RNAs that target CAG repeats: function through the RNAi pathway.
    Hu J; Liu J; Yu D; Chu Y; Corey DR
    Nucleic Acids Res; 2012 Dec; 40(22):11270-80. PubMed ID: 23042244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs.
    Hu J; Matsui M; Gagnon KT; Schwartz JC; Gabillet S; Arar K; Wu J; Bezprozvanny I; Corey DR
    Nat Biotechnol; 2009 May; 27(5):478-84. PubMed ID: 19412185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allele-specific silencing of mutant Huntington's disease gene.
    Zhang Y; Engelman J; Friedlander RM
    J Neurochem; 2009 Jan; 108(1):82-90. PubMed ID: 19094060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat.
    Gagnon KT; Pendergraff HM; Deleavey GF; Swayze EE; Potier P; Randolph J; Roesch EB; Chattopadhyaya J; Damha MJ; Bennett CF; Montaillier C; Lemaitre M; Corey DR
    Biochemistry; 2010 Nov; 49(47):10166-78. PubMed ID: 21028906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allele-selective inhibition of mutant atrophin-1 expression by duplex and single-stranded RNAs.
    Hu J; Liu J; Narayanannair KJ; Lackey JG; Kuchimanchi S; Rajeev KG; Manoharan M; Swayze EE; Lima WF; Prakash TP; Xiang Q; Martinez C; Corey DR
    Biochemistry; 2014 Jul; 53(28):4510-8. PubMed ID: 24981774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
    Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
    J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorodiamidate morpholino oligomers suppress mutant huntingtin expression and attenuate neurotoxicity.
    Sun X; Marque LO; Cordner Z; Pruitt JL; Bhat M; Li PP; Kannan G; Ladenheim EE; Moran TH; Margolis RL; Rudnicki DD
    Hum Mol Genet; 2014 Dec; 23(23):6302-17. PubMed ID: 25035419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients.
    Pfister EL; Kennington L; Straubhaar J; Wagh S; Liu W; DiFiglia M; Landwehrmeyer B; Vonsattel JP; Zamore PD; Aronin N
    Curr Biol; 2009 May; 19(9):774-8. PubMed ID: 19361997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects on murine behavior and lifespan of selectively decreasing expression of mutant huntingtin allele by supt4h knockdown.
    Cheng HM; Chern Y; Chen IH; Liu CR; Li SH; Chun SJ; Rigo F; Bennett CF; Deng N; Feng Y; Lin CS; Yan YT; Cohen SN; Cheng TH
    PLoS Genet; 2015 Mar; 11(3):e1005043. PubMed ID: 25760041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism.
    Hu J; Liu J; Corey DR
    Chem Biol; 2010 Nov; 17(11):1183-8. PubMed ID: 21095568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA duplexes with abasic substitutions are potent and allele-selective inhibitors of huntingtin and ataxin-3 expression.
    Liu J; Pendergraff H; Narayanannair KJ; Lackey JG; Kuchimanchi S; Rajeev KG; Manoharan M; Hu J; Corey DR
    Nucleic Acids Res; 2013 Oct; 41(18):8788-801. PubMed ID: 23887934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele-specific quantitation of ATXN3 and HTT transcripts in polyQ disease models.
    Joachimiak P; Ciesiołka A; Kozłowska E; Świtoński PM; Figura G; Ciołak A; Adamek G; Surdyka M; Kalinowska-Pośka Ż; Figiel M; Caron NS; Hayden MR; Fiszer A
    BMC Biol; 2023 Feb; 21(1):17. PubMed ID: 36726088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of context in RNA structure: flanking sequences reconfigure CAG motif folding in huntingtin exon 1 transcripts.
    Busan S; Weeks KM
    Biochemistry; 2013 Nov; 52(46):8219-25. PubMed ID: 24199621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ss-siRNAs allele selectively inhibit ataxin-3 expression: multiple mechanisms for an alternative gene silencing strategy.
    Liu J; Yu D; Aiba Y; Pendergraff H; Swayze EE; Lima WF; Hu J; Prakash TP; Corey DR
    Nucleic Acids Res; 2013 Nov; 41(20):9570-83. PubMed ID: 23935115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allele-selective inhibition of expression of huntingtin and ataxin-3 by RNA duplexes containing unlocked nucleic acid substitutions.
    Aiba Y; Hu J; Liu J; Xiang Q; Martinez C; Corey DR
    Biochemistry; 2013 Dec; 52(51):9329-38. PubMed ID: 24266403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and allele-specific silencing of the mutant huntingtin allele in Huntington's disease patient-derived fibroblasts.
    van Bilsen PH; Jaspers L; Lombardi MS; Odekerken JC; Burright EN; Kaemmerer WF
    Hum Gene Ther; 2008 Jul; 19(7):710-9. PubMed ID: 18549309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice.
    Lloret A; Dragileva E; Teed A; Espinola J; Fossale E; Gillis T; Lopez E; Myers RH; MacDonald ME; Wheeler VC
    Hum Mol Genet; 2006 Jun; 15(12):2015-24. PubMed ID: 16687439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.